Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.3278
-0.0322 (-8.94%)
At close: Nov 20, 2026
Vaxart Market Cap
Vaxart has a market cap or net worth of $79.89 million as of November 20, 2026. It is the 26,141st most valuable company in the world and the 4,170th biggest in the United States. Its market cap has decreased by 14.27% in one year.
Market Cap
79.89M
Enterprise Value
26.91M
Revenue
181.27M
Global Rank
Country Rank
#4,170 United States
PE Ratio
2.73
ChartMarket Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 79.89M, an increase of 32.37%. That is a compound annual growth rate of 3.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 79.89M | -3.90% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 330.64M |
| Northwest Biotherapeutics | 258.91M |
| Glorywin Entertainment Group | 234.77M |
| HST Global | 209.33M |
| BetterLife Pharma | 88.00M |
| ProText Mobility | 68.57M |
| Nuo Therapeutics | 52.79M |
| Sangamo Therapeutics | 45.57M |